NASDAQ:IMUX

Immunic Stock Insider Trading

etoro logo Buy IMUX
*Your capital is at risk
$14.17
-0.470 (-3.21%)
At Close: Jun 03, 2026

Immunic Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 42.84M and sold 0 IMUX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
100.00
Buy 42.84M shares
Sell 0 shares
100% Buy Activity
Negligible or No Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Jun 01, 2026
Buy
Common Stock
J-Other
Lundgren Erik
Officer
Officer 0
Value: $0
May 22, 2026
Buy
Stock Option
A-Award
Lundgren Erik
Chief Executive Officer
CEO / President 1 000 000
Value: $13.1M
May 16, 2026
Buy
Common Stock
J-Other
Bonney Michael W
Director 0
Value: $0
Apr 24, 2026
Buy
Stock Option
A-Award
Panzara Michael A.
Chief Medical Officer
Officer 300 000
Value: $2.64M
Apr 24, 2026
Buy
Common Stock
J-Other
Panzara Michael A.
Officer
Officer 0
Value: $0
Mar 27, 2026
Buy
Common Stock
J-Other
Congleton Jon
Director 0
Value: $0
Feb 17, 2026
Buy
Common Stock
J-Other
Nagel Robert Thorvald
Director 0
Value: $0
Feb 17, 2026
Buy
Pre-Funded Warrants to Purchase Common Stock
Bvf Partners L P/il
See Explanation Of Responses
Director 3 202 262
Value: $29.4M
Feb 17, 2026
Buy
Warrants to Purchase Common Stock
Bvf Partners L P/il
See Explanation Of Responses
Director 3 202 262
Value: $29.4M
Feb 17, 2026
Buy
Common Stock, $0.0001 par value
Bvf Partners L P/il
See Explanation Of Responses
Director 0
Value: $0
Feb 17, 2026
Buy
Common Stock, $0.0001 par value
Bvf Partners L P/il
See Explanation Of Responses
Director 0
Value: $0
Feb 17, 2026
Buy
Common Stock, $0.0001 par value
Bvf Partners L P/il
See Explanation Of Responses
Director 0
Value: $0
Jul 16, 2025
Buy
Stock Appreciation Right
A-Award
Whaley Glenn
Chief Financial Officer
C-Suite Officer 560 000
Value: $431.2K
Jul 16, 2025
Buy
Stock Appreciation Right
A-Award
Whaley Glenn
Chief Financial Officer
C-Suite Officer 280 000
Value: $215.6K
Jul 16, 2025
Buy
Stock Appreciation Right
A-Award
Nash Duane
Executive Chairman
CEO / President 630 000
Value: $485.1K
Jul 16, 2025
Buy
Stock Appreciation Right
A-Award
Nash Duane
Executive Chairman
CEO / President 315 000
Value: $242.6K
Jul 16, 2025
Buy
Stock Appreciation Right
A-Award
Vitt Daniel
CEO And Director
CEO / President 1 720 000
Value: $1.32M
Jul 16, 2025
Buy
Stock Appreciation Right
A-Award
Vitt Daniel
CEO And Director
CEO / President 860 000
Value: $662.2K
Jul 16, 2025
Buy
Stock Appreciation Right
A-Award
Muehler Andreas
Chief Medical Officer
Officer 660 000
Value: $508.2K
Jul 16, 2025
Buy
Stock Appreciation Right
A-Award
Muehler Andreas
Chief Medical Officer
Officer 330 000
Value: $254.1K
Jul 16, 2025
Buy
Stock Appreciation Right
A-Award
Tardio Jason
President And COO
CEO / President 660 000
Value: $508.2K
Jul 16, 2025
Buy
Stock Appreciation Right
A-Award
Tardio Jason
President And COO
CEO / President 330 000
Value: $254.1K
Jul 16, 2025
Buy
Stock Appreciation Right
A-Award
Tardio Jason
President And COO
CEO / President 330 000
Value: $254.1K
Jul 16, 2025
Buy
Stock Appreciation Right
A-Award
Tardio Jason
President And COO
CEO / President 660 000
Value: $508.2K
Jul 16, 2025
Buy
Stock Appreciation Right
A-Award
Muehler Andreas
Chief Medical Officer
Officer 330 000
Value: $254.1K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT IMMUNIC INC.
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and other chronic inflammatory and autoimmune diseases, as well as to treat coronavirus disease. The company i...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE